MENU
+Compare
EVO
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$4.26
Change
+$0.21 (+5.19%)
Capitalization
2.77B

EVO Evotec SE Forecast, Technical & Fundamental Analysis

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations... Show more

EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EVO with price predictions
Jul 25, 2025

EVO's RSI Oscillator ascends from oversold territory

The RSI Indicator for EVO moved out of oversold territory on July 22, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 35 similar instances when the indicator left oversold territory. In of the 35 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 57 cases where EVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 25, 2025. You may want to consider a long position or call options on EVO as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

EVO moved above its 50-day moving average on July 25, 2025 date and that indicates a change from a downward trend to an upward trend.

The 50-day moving average for EVO moved above the 200-day moving average on June 24, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where EVO advanced for three days, in of 226 cases, the price rose further within the following month. The odds of a continued upward trend are .

EVO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EVO turned negative on July 21, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for EVO crossed bearishly below the 50-day moving average on July 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 18 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EVO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for EVO entered a downward trend on July 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.218) is normal, around the industry mean (62.701). EVO has a moderately high P/E Ratio (476.190) as compared to the industry average of (88.783). EVO's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.076) is also within normal values, averaging (18.372).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
EVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EVO is expected to report earnings to fall 34.67% to -6 cents per share on August 13

Evotec SE EVO Stock Earnings Reports
Q2'25
Est.
$-0.07
Q1'25
Missed
by $0.09
Q4'24
Missed
by $0.09
Q3'24
Est.
$-0.12
Q2'24
Missed
by $0.26
The last earnings report on May 06 showed earnings per share of -10 cents, missing the estimate of -1 cents. With 87.06K shares outstanding, the current market capitalization sits at 2.77B.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
Essener Bogen 7
Phone
+49 40560810
Employees
4952
Web
https://www.evotec.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WDSCX17.950.26
+1.47%
Allspring SMID Cap Growth Fund - Cl C
CAMUX22.560.20
+0.89%
Cambiar SMID Institutional
RYCTX289.462.19
+0.76%
Rydex S&P 500 2x Strategy C
VWNDX21.990.07
+0.32%
Vanguard Windsor Investor Shares
LCGFX32.060.09
+0.28%
William Blair Large Cap Growth I

EVO and Stocks

Correlation & Price change

A.I.dvisor tells us that EVO and OGI have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EVO and OGI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EVO
1D Price
Change %
EVO100%
+5.19%
OGI - EVO
27%
Poorly correlated
+1.32%
ESPR - EVO
25%
Poorly correlated
+1.34%
ACB - EVO
23%
Poorly correlated
+0.62%
CGC - EVO
23%
Poorly correlated
+2.70%
SBFM - EVO
21%
Poorly correlated
+1.28%
More